[1]司宏伟,徐慧琴,岳峤,等.肿瘤组织乏氧与葡萄糖代谢[J].国际放射医学核医学杂志,2009,33(4):200-203.[doi:10.3760/cma.j.issn.1673-4114.2009.04.003]
　SI Hong-wei,XU Hui-qin,YUE Qiao,et al.Hypoxia and glycometabolism in cancer tissue[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(4):200-203.[doi:10.3760/cma.j.issn.1673-4114.2009.04.003]
点击复制

肿瘤组织乏氧与葡萄糖代谢(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
33
期数:
2009年第4期
页码:
200-203
栏目:
实验核医学
出版日期:
1900-01-01

文章信息/Info

Title:
Hypoxia and glycometabolism in cancer tissue
作者:
司宏伟1;  徐慧琴1;  岳峤1;  耿建华2;  陈盛祖2
1. 安徽医科大学第一附属医院核医学科, 合肥, 230022;
2. 中国医学科学院北京协和医学院肿瘤医院核医学科, 北京, 100021
Author(s):
SI Hong-wei1;  XU Hui-qin1;  YUE Qiao1;  GENG Jian-hua2;  CHEN Sheng-zu2
l. Department of Nuclear Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China;
2. Department of Nuclear Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College Cancer Hospital, Beijing 100021, China
关键词:
肿瘤; 细胞低氧; 米索硝唑; 氟脱氧葡萄糖F18
Keywords:
Neoplasms; Ceil hypoxia; Misonidarole; Fluorodeoxyglucose F18
DOI:
10.3760/cma.j.issn.1673-4114.2009.04.003
摘要:
乏氧是导致放、化疗失败原因之一,活体探知葡萄糖和乏氧代谢空间分布,有助于修订放疗计划以提高治疗效果、早期评估患者放化疗疗效和预后。18F-氟脱氧葡萄糖(18F-FDG)沉积主要依赖血流供应,与细胞摄取率关系较弱,且仅反映肿瘤细胞膜葡萄糖通量大小,无法区分有氧代谢、细胞增殖旺盛组织和乏氧组织。临床经验提示,18F-FDG综合反映肿瘤恶性程度,且葡萄糖代谢和乏氧代谢空间分布差异大者肿瘤侵袭性较强。18F-FDG和18F-氟米索硝唑的摄取总体相仿,但不能除外局部差异。目前的研究结果并不能完全否认18F-FDG可作为乏氧标志物使用,但其评估肿瘤乏氧状态的价值或特异性有限。
Abstract:
The resistant of hypoxia tumor cell to radiotherapy and chemotherapy is one of the reasons that lead to therapy failure. To detect the distribution difference of hypoxia and glycometabolism in vivo is helpful to revise radiotherapy plan in order to improve the therapeutic effect, or to evaluate the prognosis shortly after radiotherapy and chemotherapy. TTie deposition of 18F-fluorodeoxyglucose (18F-FDG) mainly depends on blood flow with weak relation to uptake rate, and only reflects the membrane flux of glucose without distinguishing aerobic metabolism, enhanced cell proliferation and hypoxia tissue. Clinical experience indicated that 18F-FDG could integratedly reflect the malignant degree of tumor for the more difference between the distribution of hypoxia and glycometabolism, the more invasion of the tumor. The distribution of 18F-FDG and 18F-fluoromisonidazole were similar in general, but can not exclude minor deference. Current studies can not deny 18F-FDG as a hypoxia agent with a limited value and specificity.

参考文献/References:

[1] Thomlinson RH,Gray LH,The histological structure of some human lung cancers and the possible implications for radiotherapy.Br J Cancer,1955, 9(4):539-549.
[2] Fyles AW,Milosevic M,Wong et al.Oxygenation predicts radiation response and survival in patients with cervix cancer.Radiother Oncol,1998,48(2):149-156.
[3] Busk M,Horsman MR,Kristjansen PE,et al.Aerobic glycolysis in cancers:implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.Int J Cancer,2008,122(12):2726-2734.
[4] Dierckx RA,Van de Wiele C.FDG uptake,a surrogate of tumour hypoxia?.Eur J Nucl Med Mol Imaging,2008,35(8):1544-1549.
[5] Wei W,Yu XD,Hypoxia-inducible factors:crosstalk between their protein stability and protein degradation.Cancer Lett,2007,257(2):145-156.
[6] Maloyan A,Eli-Berchoer L,Semenza GL,et al.HIF-lalpha-targeted pathways are activated by heat acclimation and contribute to acclimation-ischemic cross-tolerance in the heart.Physiol Genomics,2005,23(1):79-88
[7] Airley RE,Mobasheri A.Hypoxic regulation of glucose transport,anaerobic metabolism and angiogenesis in cancer novel pathways and targets for anticancer therapeutics.Chemotherapy,2007,53(4):233-256.
[8] Clavo AC,Brown RS,Wahl RL.Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia.J Nucl Med,1995,36(9):1625-1632.
[9] Thorwarth D, Eschmann SM, Holzner F,et al Combined uptake of[18F] FDC and[18F] FMISO correlates with radiation therapy outcome in head-and-neck cancer patients.Radiother Oncol,2006,80(2):151-156.
[10] Schroeder T,Yuan H,Viglianti BL,et al.Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat.Cancer Res,2005,65(12):5163-5171.
[11] Troost EG,Laverman P, Kaanders JH,et al.Imaging hypoxia after oxygenation-modificalion:comparing[18F] FMIS0 autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.Radiother Oncol,2006,80(2):157-164.
[12] Pugachev A,Ruan S,Carlin S,et al.Dependence of FDG uptake on tumor microenvironment.Int J Radiat Oncol Biol Phys,2005,62(2):545-553.
[13] Tanaka T,Furukawa T,Fujieda S,et al.Double-tracer autoradiography with Cu-ATSM/FDG and immunohistochemical interpretation in four different mouse implanted tumor models,Nucl Med Biol,2006,33(6):743-750.
[14] Picchio M,Beck R,Haubner R,et al.Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18FAZA and 125I-Gluco-RGD autoradiography.J Nucl Med,2008,49(4):597-605.
[15] Zanzonico P,O’Donoghue J,Chapman JD,et al.Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning-Eur J Nucl Med Mol Imaging,2004,31(1):117-128.
[16] Dence CS,Ponde DE, Welch MJ,et al.Autoradiographic and small-animal PET comparisons between 18F-FMISO,18F-FDG,18F-FLT and the hypoxic selective 66Cu-ATSM in a rodent model ofcancer.Nucl Med Biol,2008, 35(6):713-720.
[17] Obata A,Yoshimoto M,Kasamatsu S,et al.Intra-tiunoral distribution of 66Cu-ATSM:a comparison study with FDG.Nucl Med Biol,2003,30(5):529-534.
[18] Wyss MT,Honer M,Schubiger PA,et al.NanoPET imaging of[18F] fluoromisonidazole uptake in experimental mouse tumours.Eur J Nucl Med Mol Imaging 2006,33(3):311-318.
[19] Zanzonico P,Carapa J,Polycarpe-Holman D,et al.Animal-specific positioning molds for registration of repeat imaging studies:comparative microPET imaging of F18-labeled fluoro-deoxyglucose and fluoro-misonidazole in rodent tumors.Nucl Med Biol,2006,33(1):65-70.

相似文献/References:

[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
　He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
　Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
　Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
　Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
　zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[6]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
　Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[7]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
　Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[8]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
　Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[9]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
　Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[10]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
　Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[11]刘军叶,郭鹞,郭国祯.乏氧靶向性自杀基因治疗系统增强胰腺癌放疗效果的实验研究[J].国际放射医学核医学杂志,2006,30(3):168.
　LIU Jun-ye,GUO Yao,GUO Guo-zhen.Hypoxia-targeted suicidal gene therapy system enhances antitumor effects of radiotherapy on pancreatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(4):168.

备注/Memo

备注/Memo:
收稿日期:2009-04-07。
基金项目:安徽省自然科学基金(项目编号:090413132)
通讯作者:司宏伟,E-mail:sihw@163.com
更新日期/Last Update: 1900-01-01